Journal of Cardiovascular Magnetic Resonance · 2021 · 23 citations · 18 references
MedicineCardiologyGeneticsCardiovascular GeneticsMedical GeneticsMitochondrial GeneticsHypertrophic Cardiomyopathy GeneticsInherited CardiomyopathiesMitochondrial CardiomyopathyMitochondrial DiseaseMitochondrial DisordersLate Gadolinium Enhancement ImagingMitochondrial Dna MutationsMutationMyocardial Fibrosis DetectionNuclear Gene MutationsSarcomere Gene MutationsSarcomere Gene VariantsSarcomeric Gene Mutations
BACKGROUND: Myocardial fibrosis is an important prognostic factor in hypertrophic cardiomyopathy (HCM). However, the contribution from a wide spectrum of genetic mutations has not been well defined. We sought to investigate effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in HCM. METHODS: In 133 HCM patients, comprehensive genetic analysis was performed in 82 nuclear DNA (33 sarcomere-associated genes, 5 phenocopy genes, and 44 nuclear genes linked to mitochondrial cardiomyopathy) and 37 mitochondrial DNA. In all patients, cardiovascular magnetic resonance (CMR) was performed, including 16-segmental thickness, late gadolinium enhancement (LGE), native and post-T1, extracellular volume fraction (ECV), and T2, along with echo-Doppler evaluations. RESULTS: Patients with sarcomere mutation (SM, n = 41) had higher LGE involved segment, % LGE mass, ECV and lower post-T1 compared to patients without SM (n = 92, all p < 0.05). When classified into, non-mutation (n = 67), only mitochondria-related mutation (MM, n = 24), only-SM (n = 36) and both SM and MM (n = 5) groups, only-SM group had higher ECV and LGE than the non-mutation group (all p < 0.05). In non-LGE-involved segments, ECV was significantly higher in patients with SM. Within non-SM group, patients with any sarcomere variants of uncertain significance had higher echocardiographic Doppler E/e' (p < 0.05) and tendency of higher LGE amount and ECV (p > 0.05). However, MM group did not have significantly higher ECV or LGE amount than non-mutation group. CONCLUSIONS: SMs are significantly related to increase in myocardial fibrosis. Although, some HCM patients had pathogenic MMs, it was not associated with an increase in myocardial fibrosis.
18
Sue Richards, Nazneen Aziz, Sherri J. Bale et al. · Genetics in Medicine · 2015 · 32.2K citations · Full text
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
Carolyn Y. Ho, Sharlene M. Day, Euan A. Ashley et al. · Circulation · 2018 · 831 citations · Full text
Medicine, Cardiology, Genetics +14
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Carolyn Y. Ho, Begoña López, Otávio R. Coelho‐Filho et al. · New England Journal of Medicine · 2010 · 705 citations · Full text
Medicine, Cardiology, Genetics +13